Telix Pharmaceuticals Limited (TLX)

11.29 -0.75% (-0.09)

Over 1M: +14.2%

2026-08-28
Style
Area Line Line with markers Steps Candlesno open/high/low yet Hollow candlesno open/high/low yet Barsno open/high/low yet

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

10 11 12
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY25 — Revenue: 803.8M FY25 — Operating Cash Flow: -17.3M FY25 — Free Cash Flow: -43M FY25 — Net Income: -7.1M 0 200M 400M 600M 800M 1B
FY25
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2025-12-31, 242 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.0
ROIC 3.1%
OE margin -7.7%
Accruals 0.87%
Gross margin 53.1%
ROCE 3.2%
FCF margin -5.3%
OCF / EBIT -0.58×
OCF margin -2.2%
Profit margin -0.89%
ROA -0.61%
ROE -1.7%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.0
Segment HHI 0.64 HHI
RPO / sales —
RPO growth —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.1
Interest cover 164.5×
ND/EBITDA —
Quick ratio 1.3×
Cash / Debt 0.3×
Debt / Eq 1.2×
Net debt / Eq 0.81×
F-score 3.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.1
Sales/sh Y/Y +59.0%
EBIT CAGR +64.4%
EBIT Y/Y -46.0%
EPS Y/Y -121.6%
Div. growth —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.